Case study 5 of 5 · Decided by who pays

Reading the contract before the physician signed it

I co-founded Andwise and built software that read a physician’s employment contract and flagged the clauses worth arguing about. Each analysis went to a named reviewer, on a deadline, before the physician acted on it.

My part

Co-founder and CEO

  • Originated Andwise as co-founder.
  • Led product and company strategy, the initial $240K raise, and the physician advisory board.
The call
Wound the company down in 2024.
Turned down
Three ways to pay for it: physician subscription couldn’t fund growth, employer benefit breached confidentiality, advisor referral made the physician the product.
Result
1,200+ physician users, then a deliberate wind-down.

Reading the contract before the physician signed it · Kanav Jain · kanav.net

Andwise Contract Analyzer design — a detected contract clause with a confidence label, physician- and employer-friendly framing side by side, and a handling decision
The Contract Analyzer as specified in January 2023. This is the design artifact, not a screenshot of a live analysis — the document body is placeholder text.

Early-career physicians faced high-stakes financial decisions on debt, contracts, and home buying with no unbiased guidance.

I originated the Contract Analyzer’s clause-level language analysis for physician employment agreements. It targeted post-termination restrictive covenants, ambiguous responsibility for tail coverage, and call-duty allocations. The software surfaced the relevant contract language for review; a flag was not a legal conclusion. I drew the line between analysis and advice in the product itself, with every analysis routed on an escalation clock to a named reviewer for sign-off.

Direct physician subscription Not chosen

The aligned option: the physician pays, so the product answers to the physician. What it could not do was fund growth — acquisition cost exceeded lifetime value at every price we tested.

Hospital or employer benefit Not chosen

The employer pays and the product is sold as a benefit. It meant a twelve-month sales cycle and reporting on which employees used it. That reporting would have breached the confidentiality the product existed to protect.

Advisory or wealth-manager referral Not chosen

The highest revenue per user, and the one that inverts the premise: the advisor pays for the introduction, so the physician becomes the product rather than the customer.

To the medical advisory board on 29 May 2024: “we haven’t been able to overcome financial hurdles and achieve the user engagement we’d hoped for. As a result, we’ve made the tough decision to wind down operations.”

I should have tested who would pay in year one. I left it until year two.

Where the analysis stopped

It did

  • Surfaced the clauses worth arguing about, highlighted in the contract itself.
  • Explained each one in plain language, with a stated confidence level.
  • Showed physician-friendly and employer-friendly framing side by side.
  • Routed every analysis to a named reviewer on an escalation clock.

It did not

  • Advise. The analysis surfaced and explained, and stopped there.
  • Decide how a clause should be handled. Accepting, raising, or escalating to a lawyer stayed the physician’s choice.
  • Author legal content — that was a JD’s job, not the software’s.

I convened a physician medical advisory board, designed review routing with escalation clocks, and shipped plain-language summaries signed off by a named reviewer. Alongside the Contract Analyzer, Andwise kept a free directory of more than 70 financial advisory firms and took no payment for a listing. 2 3

1 Physician submits contract for review → 2 Initial automated analysis flags the clauses worth arguing about → 3 If flagged: escalation timer starts, reviewer notified → 4 Plain-language summary delivered with sign-off

Andwise reached 1,200+ physician users, but sustained engagement and funding fell short.

Who pays decides who the product works for. Sign-ups show people want it; they do not settle that.

Software changed the economics of expert advice here: it cut the labor per analysis, while trust, context, and a named reviewer’s time stayed as expensive as ever. The cost moved; it did not disappear.

Advisory and fractional product leadership for healthcare and AI ventures. I partner with technical founders to take complex clinical systems through review, unblock patient adoption, and build products that last.

1 Andwise founding

Andwise was co-founded by Kanav Jain and Dr. Varun Verma in 2022.

Andwise’s own page naming its founders.

2 Medical advisory board

Andwise maintained a physician medical advisory board. The public roster names 21 physicians, including co-founder Dr. Varun Verma.

The advisory board’s public roster, counted on 28 August 2026: 21 named physicians. The page is a 2024 snapshot of a site no longer maintained, so it may miss people who served at other times.

3 Advisor directory

Andwise published a directory of financial advisors for physicians and took no compensation for listings.

The directory’s own disclaimer: Andwise “is not affiliated with any of the advisors listed and does not receive compensation for their presence in our directory.”

Documents described, not republished

  • Physician medical advisory board The public roster survives; no charter does. The review scope and authority described here come from my records.
  • The 29 May 2024 wind-down email The email to the medical advisory board and April 2023 investor updates, recording the decision to wind down operations rather than build on an unaligned employer or financial advisor referral model.

Andwise wound down in 2024 and most of its internal working documents did not survive. Public sources above confirm the founding, the advisory-board roster, and the directory’s terms. The wind-down email and the investor updates come from my own email.

Revised